Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Human Gene Therapy
|
September 12, 2022
Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1
Richard H Smith, Hanan Bloomer, Danielle Fink, et al.
Blood Advances
|
December 18, 2025
10-year experience of CD22 CAR T-cells for children and young adults with B-cell acute lymphoblastic leukemia
Alexandra Dreyzin, Bonnie Yates, Haneen N Shalabi, et al.
Molecular Cancer Therapeutics
|
February 26, 2021
Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T Cells
Alka Dwivedi, Atharva Karulkar, Sarbari Ghosh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2020
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
Nirali N Shah, Steven L Highfill, Haneen Shalabi, et al.
Journal for Immunotherapy of Cancer
|
June 5, 2026
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results
Sara K Silbert, Flavia Gava, Bonnie Yates, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 29, 2023
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain
Lekha Mikkilineni, Danielle A Natrakul, Norris Lam, et al.
Blood Advances
|
December 7, 2020
NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous disease
Suk See De Ravin, Julie Brault, Ronald J Meis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2023
Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
Daniel S Green, Franklin Ning, Anna Duemler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2022
Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
Daniel S Green, Franklin Ning, Anna Duemler, et al.
The Lancet. Haematology
|
March 16, 2025
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study
Hasmukh Jain, Atharva Karulkar, Devanshi Kalra, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Human Gene Therapy
|
September 12, 2022
Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1
Richard H Smith, Hanan Bloomer, Danielle Fink, et al.
Blood Advances
|
December 18, 2025
10-year experience of CD22 CAR T-cells for children and young adults with B-cell acute lymphoblastic leukemia
Alexandra Dreyzin, Bonnie Yates, Haneen N Shalabi, et al.
Molecular Cancer Therapeutics
|
February 26, 2021
Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T Cells
Alka Dwivedi, Atharva Karulkar, Sarbari Ghosh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2020
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
Nirali N Shah, Steven L Highfill, Haneen Shalabi, et al.
Journal for Immunotherapy of Cancer
|
June 5, 2026
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results
Sara K Silbert, Flavia Gava, Bonnie Yates, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 29, 2023
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain
Lekha Mikkilineni, Danielle A Natrakul, Norris Lam, et al.
Blood Advances
|
December 7, 2020
NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous disease
Suk See De Ravin, Julie Brault, Ronald J Meis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2023
Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
Daniel S Green, Franklin Ning, Anna Duemler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2022
Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
Daniel S Green, Franklin Ning, Anna Duemler, et al.
The Lancet. Haematology
|
March 16, 2025
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study
Hasmukh Jain, Atharva Karulkar, Devanshi Kalra, et al.
Page
of 6